Epivir HBV and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Epivir HBV and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lamivudine
Brand name: Epivir, Epivir HBV
Synonyms: Epivir-HBV
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epivir HBV-Insulin glulisine
- Epivir HBV-Insulin Glulisine (Cartridges and Pens)
- Epivir HBV-Insulin Glulisine (Vials)
- Epivir HBV-Insulin glulisine Subcutaneous
- Epivir HBV-Insulin human inhaled Inhalation
- Epivir HBV-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Epivir-HBV (Lamivudine Oral Solution)
- Insulin glargine, recombinant Subcutaneous-Epivir-HBV (Lamivudine Tablets)
- Insulin glargine, recombinant Subcutaneous-Eplerenone
- Insulin glargine, recombinant Subcutaneous-Epoetin alfa
- Insulin glargine, recombinant Subcutaneous-Epoetin alfa Injection
- Insulin glargine, recombinant Subcutaneous-Epoetin Alfa Vials